PDLIM2 and lung carcinoma: In line with their ability in restoring PDLIM2 expression in lung cancer cells, epigenetic drugs 5-aza-dC and MS-275 could increase MHC-I expression in both mouse and human lung cancer cells (Fig. 5c, Supplementary Fig. 6d).